Willett, W. C., B. F. Polk, B. A. Underwood, M. J. Stampfer, S. Pressel, B. Rosner, J. O. Taylor, K. Schneider, and C. G. Hames. 1984. Relation of serum vitamins A and E and carotenoids to the risk of cancer. New England Journal of Medicine 310(7):430–434.
Williams, S. A., D. E. Slavin, J. A. Wagner, and C. J. Webster. 2006. A cost-effectiveness approach to the qualification and acceptance of biomarkers. Nature Reviews Drug Discovery 5(11):897–902.
Writing Group Members, F. S. Apple, A. H. Wu, A. S. Jaffe, M. Panteghini, R. H. Christenson, NACB Committee Members, R. H. Christenson, F. S. Apple, C. P. Cannon, G. S. Frances, R. L. Jesse, D. A. Morrow, L. K. Newby, A. B. Storrow, W. H. Tang, A. H. Wu, IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD) Members, F. S. Apple, C. P. Cannon, A. S. Jaffe, F. Pagani, J. Tate, J. Ordonez-Llanos, and J. Mair. 2008. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. Clinical Biochemistry 41(4-5):222–226.
Wu, Alan H.B. 2010. Standardization of assays for clinically important enzymes that have biologic variation: what is all the fuss about? Clinical Chemistry and Laboratory Medicine 48(3)299–300.